According to a new report Global Cardiac Biomarkers Testing Market, published by KBV research, The Global Cardiac Biomarkers Testing Market size is expected to reach $16.2 billion by 2025, rising at a market growth of 11.4% CAGR during the forecast period.
The North America market dominated the Global Creatine Kinase (CK-MB) Market by Region in 2018, growing at a CAGR of 9.9 % during the forecast period. The Europe market is expected to witness a CAGR of 10.3% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 12% during (2019-2025).
The Myocardial Infarction market dominated the Global Cardiac Biomarkers Testing Market by Application in 2018, growing at a CAGR of 11 % during the forecast period. The Congestive Heart Failure market is expected to witness a CAGR of 12.5% during (2019-2025). Additionally, The Acute Coronary Syndrome market is expected to witness highest CAGR of 10.9% during (2019-2025).
The Laboratory Testing market dominated the Global Cardiac Biomarkers Testing Market by Location of Testing in 2018, growing at a CAGR of 10.3 % during the forecast period. The Point of Care Testing market is expected to witness highest CAGR of 13.6% during (2019-2025).
Full Report: https://www.kbvresearch.com/cardiac-biomarkers-testing-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.
Global Cardiac Biomarkers Testing Market Segmentation
By Type
Creatine Kinase (CK-MB)
Troponins
Myoglobin
Natriuretic Peptides (BNP and NT-proBNP)
Ischemia Modified Albumin
Others
By Application
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others
By Location of Testing
Point of Care Testing
Laboratory Testing
By Geography
North America
US
Canada
Mexico
Rest of North America
Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Companies Profiled
Trivitron Healthcare Pvt. Ltd.
Abbott Laboratories
Siemens AG
Becton, Dickinson AND Company
Bio-Rad Laboratories, Inc.
Randox Laboratories Limited
Danaher Corporation
Thermo Fisher Scientific, Inc.
Johnson and Johnson
Quidel Corporation
Cardiac Biomarkers Testing Market Related Reports:
North America Market
Europe Market
Asia Pacific Market
LAMEA Market
